Clinical Trial Update: A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause [Phase 2]

View source ↗

Summary

Phase 2 study of NOE-115 in women with vasomotor symptoms due to menopause has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hot Flashes
• Menopause

Drugs mentioned

• NOE-115

Snippet

Sponsor: Noema Pharma AG | Conditions: Menopause Syndrome, Menopause | Phase 2 | Status: COMPLETED